Revisiting the scaling of the specific heat of the three-dimensional random-field Ising model

We revisit the scaling behavior of the specific heat of the three-dimensional random-field Ising model with a Gaussian distribution of the disorder. Exact ground states of the model are obtained using graph-theoretical algorithms for different strengths = 268 3 spins. By numerically differentiating the bond energy with respect to h, a specific-heat-like quantity is obtained whose maximum is found to converge to a constant in the thermodynamic limit. Compared to a previous study following the same approach, we have studied here much larger system sizes with an increased statistical accuracy. We discuss the relevance of our results under the prism of a modified Rushbrooke inequality for the case of a saturating specific heat. Finally, as a byproduct of our analysis, we provide high-accuracy estimates of the critical field hc = 2.279(7) and the critical exponent of the correlation exponent ν = 1.37(1), in excellent agreement to the most recent computations in the literature

Quasielastic axial-vector mass from experiments on neutrino-nucleus scattering

We analyze available experimental data on the total and differential charged-current cross sections for quasielastic neutrino and antineutrino scattering off nucleons, measured with a variety of nuclear targets in the accelerator experiments at ANL, BNL, FNAL, CERN, and IHEP, dating from the end of sixties to the present day. The data are used to adjust the poorly known value of the axial-vector mass of the nucleon.Comment: 27 pages, 19 figures. Typos corrected; tables, figures and references added, discussion extended; matches published versio

Non-target and suspect screening strategies for electrodialytic soil remediation evaluation: Assessing changes in the molecular fingerprints and per- And polyfluoroalkyl substances (PFASs)

Contamination of soils with organic pollutants is an increasing global problem, so novel soil remediation techniques are urgently needed. One such technique is electrokinetic remediation, in which an electric field is applied over the soil to extract contaminants. Previous evaluations of the technique have been limited to a few specific compounds. In this study, we integrated the latest advances in high-resolution mass spectrometry (HRMS) to identify molecular fingerprints, and used the results to improve the mechanistic understanding necessary for successful remediation. A laboratory-scale 0.38 mA cm-2 electrodialytic treatment was applied for 21 days to a contaminated soil from a firefighter training facility in Sweden. Non-target analysis allowed generic evaluation of changes in the soil organic fraction by tentatively determining the elemental composition of compounds present. The results showed that smaller oxygen-rich molecules were significantly transported to the anode by electromigration, while larger hydrogen-saturated molecules were transported to the cathode by electroosmotic flow. Wide suspect screening with >3000 per- and polyfluoroalkyl substances (PFASs) tentatively identified seven new PFASs in the test soil, including perfluoroheptanesulfonic acid (PFHpS), and PFASs with butoxy, ethoxy, ethanol, and ethylcyclohexanesulfonate functional groups. © 2020 The Author(s)

Universality aspects of the trimodal random-field Ising model

We investigate the critical properties of the d = 3 random-field Ising model with an equal-weight trimodal distribution at zero temperature. By implementing suitable graph-theoretical algorithms, we compute large ensembles of ground states for several values of the disorder strength h and system sizes up to N = 1283. Using a new approach based on the sample-to-sample fluctuations of the order parameter of the system and proper finite-size scaling techniques we estimate the critical disorder strength hc = 2.747(3) and the critical exponents of the correlation length ν = 1.34(6) and order parameter β = 0.016(4). These estimates place the model into the universality class of the corresponding Gaussian random-field Ising model

Efeitos cardiorrespiratórios do butorfanol em cães pré-tratados ou não pela levomepromazina Cardiopulmonary effects of butorphanol in dogs treated with levomepromazine

Objetivou-se com este experimento avaliar os efeitos do butorfanol precedido ou não pela levomepromazina sobre a freqüência cardíaca (FC), as pressões arteriais sistólica, diastólica e média (PAS, PAD e PAM, respectivamente), a freqüência respiratória (f), a concentração de dióxido de carbono ao final da expiração (ETCO2), a saturação da oxihemoglobina (SpO2), o volume corrente (VC) e o volume minuto (VM), em cães. Para tal, foram empregados vinte animais adultos, clinicamente saudáveis, distribuídos igualmente em dois grupos (GC e GL). Ao GC administrou-se solução salina a 0,9% (Controle), no volume de 0,2mL kg-1, pela via intravenosa (IV). Decorridos 15 minutos, administrou-se butorfanol na dose de 0,3mg kg-1 pela mesma via. Aos animais do GL foi adotada a mesma metodologia, porém substituindo-se a solução salina pela levomepromazina na dose de 1mg kg-1. As medidas das variáveis cardiorrespiratórias iniciaram-se imediatamente antes da aplicação dos fármacos (M1). Novas mensurações foram realizadas 15 minutos após a administração da solução salina a 0,9% ou levomepromazina (M2) e 10 minutos após a administração de butorfanol (M3). As demais colheitas foram realizadas a intervalos de 10 minutos, durante 30 minutos (M4, M5 e M6, respectivamente). Os dados numéricos colhidos foram submetidos à Análise de Variância (ANOVA), seguida pelo teste de Tukey (p<0,05) para as comparações das médias. O emprego do butorfanol promoveu diminuição significativa das freqüências cardíaca e respiratória e do volume minuto no grupo previamente tratado pela levomepromazina; entretanto, essas alterações foram discretas, não comprometendo os demais parâmetros circulatórios e respiratórios.<br>This work was aimed at evaluating the effects of the butorphanol in dogs preceded or not buy levomepromazine on heart rate (HR), systolic, diastolic and mean arterial pressure (SAP, DAP and MAP, respectively), respiratory rate (RR), end tidal CO2 (ETCO2), oxyhemoglobin saturation (SpO2), minute volume (MV) and tidal volume (TV). Twenty adult animals, clinically health were randomly distributed in two groups with ten animals each one (CG and LG). The first one received intravenous administration (IV) of 0.2mL kg-1 of saline solution at 0.9% (control). After 15 minutes, 0.3mg kg-1 of butorphanol was administrated by the same way. The same methodology was adopted to the GL animals, however, the saline solution at 0.9% was substituted to 1mg kg-1 of levomepromazine. The cardiorespiratory parameters were measured before the administration of the drugs (M1). New measurements were carried 15 minutes after saline or levomepromazine administration (M2), and 10 minutes after butorphanol administration (M3). The next M4, M5 and M6 were carried out through at intervals of 10 minutes during 30 minutes. The numeric data were submitted to the Analysis of Variance (ANOVA) followed by Tukey test (p<0.05) for the comparisons of the averages. The butorfanol promoted significative decreasing on cardiac and respiratory rate and reduction on minute volume after administration of levomepromazine. However these changes were discreet and did not produce depression on other circulatory and breathing parameters

Does hospital admission provide an opportunity for improving pharmacotherapy among elderly inpatients?

ABSTRACT The purpose of the work was to assess the incidence of potential drug interactions (pDDI), major pDDI, and the use of potentially inappropriate medication (PIM) at hospital admission, during hospitalization, and at discharge to evaluate whether hospital admission provides an opportunity for improving pharmacotherapy in elderly patients at a University hospital that has a clinical pharmacist. A prospective cohort study was carried out using data from the medical records of patients admitted to an internal medicine ward. All admissions and prescriptions were monitored between March and August 2006. Micromedex(r) DrugReax(r) and Beers Criteria 2015 were used to identify pDDI, major pDDI, and PIMs, respectively. A comparison of admission and discharge prescriptions showed the following: an increase in the proportion of patients using antithrombotic agents (76 versus 144; p<0.001), lipid modifying agents (58 versus 81; p=0.024), drugs for acid-related disorders (99 versus 152; p<0.001), and particularly omeprazole (61 versus 87; p=0.015); a decrease in the number of patients prescribed psycholeptics (73 versus 32; p<0.001) and diazepam (54 versus 13; p<0.001); and a decrease in the proportion of patients exposed to polypharmacy (16.1% versus 10.1%; p=0.025), at least one pDDI (44.5% versus 32.8%; p=0.002), major pDDI (19.9% versus 12.2%; p=0.010) or PIM (85.8% versus 51.9%; p<0.001). The conclusion is that admission to a hospital ward that has a clinical pharmacist was associated with a reduction in the number of patients exposed to polypharmacy, pDDI, major pDDI, and the use of PIMs among elderly inpatients